Revisiting the role of radical surgery in early stage prostate cancer

Anthony J Costello, Niall M Corcoran and Scott Van Appledorn
Med J Aust 2005; 183 (6): . || doi: 10.5694/j.1326-5377.2005.tb07055.x
Published online: 19 September 2005

Is it time to walk the line between overtreating indolent disease and undertreating aggressive disease?

Few other health care issues in Australia have been as contentious as the diagnosis and treatment of early prostate cancer. Debate centres on two hotly contested but important issues: do prostate cancers diagnosed by an elevated serum prostate-specific antigen (PSA) level pose a significant threat to health, and if they do, can intervention alter the natural history of the disease? In this editorial, we consider the contribution that two recently published studies make to this debate, with a focus on survival and the role of surgical management.

  • Anthony J Costello1
  • Niall M Corcoran2
  • Scott Van Appledorn3

  • Department of Urology, The Royal Melbourne Hospital, Melbourne, VIC.



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.